Wire · opportunities
From lab to life: Global collaboration urged to transform biotech innovation
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 10 September 2026 · Fusion42 review
China's Greater Bay Area is advancing an integrated biotech innovation ecosystem driven by regulatory reforms such as the '818 decree', new clinical trial infrastructure, and cross-border collaboration under the 'one country, two systems' framework. This strategic push supports accelerated patient access to novel therapies and positions Hong Kong as a regional R&D hub amidst record biotech investment and increasing international trade friction.
This Wire brief sits within Fusion42's coverage of Biotech.
◆ ◆ The Wire takeaway
Hong Kong's biotech founders must act now to leverage the new '818 decree' regulatory pathways and Greater Bay Area clinical trial infrastructure to accelerate product development and market entry. The region's unique geopolitical status opens global collaboration opportunities while challenging competitors face tougher trade barriers.
◆ Coverage
1 source · 10 Sep 2026
◆ Related on Wire
◆ Topics